Department of Medicine, The University of Melbourne, Parkville, VIC, Australia.
Department of Rehabilitation Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.
NeuroRehabilitation. 2021;48(2):243-245. doi: 10.3233/NRE-218000.
Progressive muscle weakness is a feature of neuromuscular diseases (NMDs), a heterogeneous group of conditions with variable onset, presentation and prognosis that affect both children and adults. Respiratory muscle weakness compromises respiratory function and may lead to respiratory failure.
To assess the effects of respiratory muscle training (RMT) in adults and children with NMD.
A Cochrane Review by Silva et al. was summarized with comments.
Eleven studies involving 250 randomized participants with NMD were included. While the studies showed that RMT may lead to improvements in lung function and respiratory muscle strength in people with ALS and DMD, this was not a consistent finding. The evidence from all the included trials was of low or very low certainty.
There may be some improvement in lung capacity and respiratory muscle strength following RMT in some NMD. There appears to be no clinically meaningful effect of RMT on physical functioning and quality of life in ALS. The low certainty of the evidence means that the results need to be interpreted with caution.
进行性肌肉无力是神经肌肉疾病(NMD)的特征之一,NMD 是一组异质性疾病,其发病、表现和预后各不相同,可影响儿童和成人。呼吸肌无力会影响呼吸功能,并可能导致呼吸衰竭。
评估呼吸肌训练(RMT)对 NMD 成人和儿童的疗效。
对 Silva 等人的 Cochrane 综述进行总结并添加点评。
纳入了 11 项涉及 250 名随机 NMD 参与者的研究。尽管这些研究表明 RMT 可能会改善 ALS 和 DMD 患者的肺功能和呼吸肌力量,但这并非一致发现。所有纳入试验的证据质量均为低或极低。
在某些 NMD 中,RMT 后可能会使肺活量和呼吸肌力量有所改善。RMT 对 ALS 患者的身体机能和生活质量似乎没有明显的临床影响。证据的确定性低意味着结果需要谨慎解释。